RETRACTED: Usefulness of Monitoring Platelet Function by Multiple Electrode Aggregometry in Primary Coronary Artery Bypass Surgery (Retracted article. See vol. 25, pg. 757, 2011)

被引:9
作者
Mengistu, Andinet M. [1 ]
Mayer, Jochen [1 ]
Boldt, Joachim [1 ]
Roehm, Kerstin D. [1 ]
Suttner, Stefan W. [1 ]
机构
[1] Klinikum Ludwigshafen, Dept Anesthesiol & Intens Care Med, D-67063 Ludwigshafen, Germany
关键词
multiple-electrode aggregometry; acetylsalicylic acid; clopidogrel; point of care; cardiac surgery; platelet function; OF-THORACIC-SURGEONS; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; WHOLE-BLOOD; PREOPERATIVE ASPIRIN; PRACTICE GUIDELINE; FUNCTION ANALYZER; GRAFT-SURGERY; TRANSFUSION; CLOPIDOGREL;
D O I
10.1053/j.jvca.2010.02.008
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Antiplatelet therapy is commonly used for the prevention of cardiovascular complications but increases the risk of perioperative bleeding. Multiple-electrode aggregometry (MEA) was investigated for monitoring platelet inhibition by acetylsalicylic acid (ASA) and clopidogrel in patients undergoing elective coronary artery bypass graft (CABG) surgery with regard to clinical outcome as measured by postoperative blood loss and transfusion requirements. Design: A prospective observational study. Setting: A teaching hospital. Participants: One hundred fifty patients scheduled for elective CABG surgery were included: without antiplatelet therapy (group A, n = 50), single ASA exposure (group B, n = 50), and combined therapy with ASA and clopidogrel (group C, n = 50). Measurements and Main Results: MEA was assessed preoperatively using either collagen (COL-MEA) or ADP (ADP-MEA). Postoperative blood loss and transfusion requirements were recorded for 24 hours after surgery. Postoperative blood loss significantly increased only from combined antiplatelet therapy (group A: 572 +/- 297 mL, group B: 721 +/- 356 mL, group C: 865 +/- 346, p < 0.01) and correlated with ADP (r(p) = -0.35, p < 0.01) and COL-MEA (r(p) = -0.23, p > 0.01). COL-MEA and ADP-MEA discriminated between preoperative ASA and clopidogrel intake (ASA: sensitivity = 86.3%, and specificity = 89.3%; clopidogrel: sensitivity = 87.5%, and specificity = 95.1%). The postoperative transfusion risk was increased in patients diagnosed for clopidogrel treatment by ADP-MEA (odds ratio = 2.92; confidence interval: 1.44-5.92; p = 0.005). Conclusions: MEA is a suitable method for the detection of platelet inhibition by ASA and clopidogrel in patients undergoing CABG surgery. In these patients, preoperative ADP MEA seems to indicate patients at risk for postoperative transfusion requirements. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 47
页数:6
相关论文
共 30 条
[21]   Platelet concentrates transfusion in cardiac surgery and platelet function assessment by multiple electrode aggregometry [J].
Rahe-Meyer, N. ;
Winterhalter, M. ;
Boden, A. ;
Froemke, C. ;
Piepenbrock, S. ;
Calatzis, A. ;
Solomon, C. .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 (02) :168-175
[22]   An Evaluation of Cyclooxygenase-1 Inhibition Before Coronary Artery Surgery: Aggregometry Versus Patient Self-Reporting [J].
Rahe-Meyer, Niels ;
Winterhalter, Michael ;
Hartmann, Julia ;
Pattison, Albert ;
Hecker, Hartmut ;
Calatzis, Andreas ;
Solomon, Cristina .
ANESTHESIA AND ANALGESIA, 2008, 107 (06) :1791-1797
[23]   Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel [J].
Ray, Joel G. ;
Deniz, Stacy ;
Olivieri, Anthony ;
Pollex, Erika ;
Vermeulen, Marian J. ;
Alexander, Kurian S. ;
Cain, David J. ;
Cybulsky, Irene ;
Hamielec, Cindy M. .
BMC CARDIOVASCULAR DISORDERS, 2003, 3 (1)
[24]   RELATIONSHIP OF FIBRINOLYSIS AND PLATELET-FUNCTION TO BLEEDING AFTER CARDIOPULMONARY BYPASS [J].
RAY, MJ ;
MARSH, NA ;
HAWSON, GAT .
BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) :679-685
[25]   P2Y12, a new platelet ADP receptor, target of clopidogrel [J].
Savi, P ;
Labouret, C ;
Delesque, N ;
Guette, F ;
Lupker, J ;
Herbert, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) :379-383
[26]   Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests [J].
Shenkman, Boris ;
Matetzky, Shlomi ;
Fefer, Paul ;
Hod, Hanoch ;
Einav, Yulia ;
Lubetsky, Aharon ;
Varon, David ;
Savion, Naphtali .
THROMBOSIS RESEARCH, 2008, 122 (03) :336-345
[27]   Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes [J].
Spiess, BD ;
Royston, D ;
Levy, JH ;
Fitch, J ;
Dietrich, W ;
Body, S ;
Murkin, J ;
Nadel, A .
TRANSFUSION, 2004, 44 (08) :1143-1148
[28]   The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies [J].
Sun, Jack C. J. ;
Whitlock, Richard ;
Cheng, Ji ;
Eikelboom, John W. ;
Thabane, Lehana ;
Crowther, Mark A. ;
Teoh, Kevin H. T. .
EUROPEAN HEART JOURNAL, 2008, 29 (08) :1057-1071
[29]   INHIBITION OF PROSTAGLANDIN SYNTHESIS AS A MECHANISM OF ACTION FOR ASPIRIN-LIKE DRUGS [J].
VANE, JR .
NATURE-NEW BIOLOGY, 1971, 231 (25) :232-&
[30]   An Assessment of Cardiopulmonary Bypass-Induced Changes in Platelet Function Using Whole Blood and Classical Light Transmission Aggregometry: The Results of a Pilot Study [J].
Velik-Salchner, Corinna ;
Maier, Stephan ;
Innerhofer, Petra ;
Kolbitsch, Christian ;
Streif, Werner ;
Mittermayr, Markus ;
Praxmarer, Michael ;
Fries, Dietmar .
ANESTHESIA AND ANALGESIA, 2009, 108 (06) :1747-1754